Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MYC | P01106 | 1/20 | 0.36 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | CRHBP | P24387 | 1/20 | 0.34 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.34 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.33 |
| ▸ | GSK3B | P49841 | 1/20 | 0.33 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12640469 | 0.99 | MYC (0.38) | MYCSCN9APTGDR2GABRA1GABRG2 | |
| SCHEMBL12640521 | 0.96 | MYC (0.38) | MYCSCN9APTGDR2GABRA1GABRG2 | |
| SCHEMBL10040890 | 0.95 | ABCG2 (0.38) | MYCPTGDR2GABRA1GABRG2GABRB3 | |
| SCHEMBL12640426 | 0.93 | PGR (0.37) | PTGDR2PGRHRH3TSHRMMP3 | |
| SCHEMBL12640564 | 0.92 | MYC (0.35) | MYCSCN9AGABRA1GABRG2GABRB3 | |
| SCHEMBL12575857 | 0.91 | SCN9A (0.32) | MYCSCN9APTGDR2GABRA1GABRG2 | |
| SCHEMBL17933038 | 0.91 | ABCG2 (0.40) | MYCSCN9APTGDR2GABRA1GABRG2 | |
| SCHEMBL12640432 | 0.91 | PTGDR2 (0.42) | MYCPTGDR2GABRA1GABRG2GABRB3 | |
| SCHEMBL12640522 | 0.91 | PTGDR2 (0.42) | MYCPTGDR2GABRA1GABRG2GABRB3 | |
| SCHEMBL12640480 | 0.91 | ABCG2 (0.36) | MYCSCN9APTGDR2GABRA1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9126892-B2 | Blue fluorescence compound and organic electroluminescence device using the same | LG DISPLAY CO., LTD. (KR) | 2015-09-08 | — | — | US | disclosed |
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110156011-A1 | BLUE FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | KCNN2, ORAI2, ETV6 | MYC 182/4885SCN9A 1378/4885PTGDR2 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.